Complimentary Webinar: Application of TALLman Lettering for Selected High Alert Drugs in Canada
ISMP Canada (Institute for Safe Medication Practices Canada) is pleased to offer this complimentary webinar to Canadian healthcare facilities and practitioners with support from Health Canada’s Canadian Medication Incident Reporting and Prevention System.
Drug name confusion, particularly because of look-alike, sound-alike (LASA) name attributes can be a contributing factor to medication related adverse events. TALLman lettering is one of many risk mitigation strategies to minimize errors involving LASA drug names.
ISMP Canada invites healthcare professionals to participate in a one hour complimentary webinar that will provide an opportunity for participants to learn more about the development of a list of “TALLman Lettering for Look-alike/Sound-Alike Drug Names in Canada”.